Revenue grew 17.7% to $645.7 million versus $548.6 million in the period a year ago.
Schulman also boosted its full year outlook calling for income excluding items to be in a range of $2.31 to $2.36 per diluted share versus the average analyst expectation of $2.27.
Must Read: Warren Buffett's 25 Favorite Stocks
STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.